coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    West Of Waverley PCN, Waverley · Health Inequalities Profile

    PCN U39739 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    47,611

    Registered population

    56.6% aged 18–64

    24.3%

    Aged 65+

    ICB 18.8% · England 17.9%

    5.3%

    Ethnic minority (non-White)

    2.2% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    7,897

    Hypertension register

    +6.65% in 3 yrs · England +5.60%

    405

    SMI register

    30.8% of Waverley's

    641

    COPD register

    Reviews +1.06% in 3 yrs

    Forecast to 2030

    9,398

    Hypertension patients, 2030

    +1,501 on today

    68.7%

    QRISK ≥20% on statins, 2030

    +4.40pp over 3 yrs

    6.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    65.7%
    Heart failure reviews trail national and ICB averages.

    Annual heart failure reviews fell 6.7% over three years (England +8.7%) to 65.7%, below Waverley (67.9%), England (78.5%) and the ICB (79.9%).

    58.8%
    High-risk lipid therapy and diabetes statins lag England.

    Lipid-lowering therapy in QRISK ≥ 20% is 58.8% (England 63.6%), while statin treatment in diabetes without CVD is 68.3% (England 73.2%).

    +10.5%
    Asthma review coverage grew faster than national trend.

    Asthma annual reviews rose +10.5% over three years (England +4.4%) to 65.7% (England 65.7%), though about 1,100 register patients remain unreviewed.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older adults comprise 24.3% of the PCN list, well above the England average

    West of Waverley PCN serves 47,611 registered patients. Patients aged 65+ represent 24.3% of the list (11,583 patients), higher than Waverley (22.0%), NHS Surrey Heartlands Integrated Care Board (18.8%) and England (17.9%). The 18–64 age band accounts for 56.6% (26,966 patients) and aged 0–17 for 19.0% (9,062 patients). Area Census resident data shows 94.7% White (Waverley 93.6%, ICB 85.3%, England 81.1%) and 2.2% Asian / Asian British (Waverley 2.8%, ICB 7.7%, England 9.6%). Census ethnicity reflects usual residents rather than registered patients.

    Age profile

    0–1719.0%
    18–6456.6%
    65+24.3%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White94.7%
    Asian2.2%
    Mixed2.1%
    Other0.6%
    Black0.5%

    Older people · falls rows are Waverley local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Waverley LA)2,1642,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.4%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.6%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Waverley LA)9129819552024/25
    Falls deaths, all ages, per 100,000 (Waverley LA)9.614.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    West of Waverley records 0.0% Core20 deprivation with an 8.2 average IMD decile

    West of Waverley PCN records 0.0% Core20 deprivation, matching Waverley (0.0%), below NHS Surrey Heartlands Integrated Care Board (0.8%) and England (21.0%). Estimated Core20 count is 0 across all four practices, reconciling with the 0.00% weighted practice share. The PCN average IMD decile is 8.2 (Waverley 8.5, NHS Surrey Heartlands Integrated Care Board 7.9, England 5.5), ranging from 7.6 at Witley Surgery and 7.8 at Chiddingfold Surgery to 8.4 at Haslemere Health Centre and Grayshott Surgery. Health inequality initiatives may need to target specific clinical cohorts rather than area deprivation.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Chiddingfold0.0% · 0 patients
    Witley0.0% · 0 patients
    Haslemere0.0% · 0 patients
    Grayshott0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    405

    SMI register

    0.84% recorded prevalence

    322

    Learning disability register

    0.67% recorded prevalence

    40

    Care homes, 1,536 beds

    In the PCN catchment

    7.8%

    Provide unpaid care

    Waverley, Census 2021

    The PCN records 322 learning disability patients (0.7% prevalence, above Waverley at 0.5%, NHS Surrey Heartlands Integrated Care Board at 0.5% and England at 0.6%) and 405 severe mental illness patients (0.8% prevalence). Catchment care homes total 40 with 1,536 beds. At borough level, Waverley recorded a 7.8% unpaid care rate and 4 rough sleepers in autumn 2025.

    Severe mental illness: physical health checks

    SMI recorded prevalence is 0.8%. Blood pressure checks reached 83.2% (England 83.4%) and BMI recording was 80.3% (England 82.1%), trailing at Witley Surgery (72.7% BP; 71.2% BMI). This gap may reflect separate recall workflows, which local audits could test.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,897

    Hypertension register

    +6.65%

    Register growth, 3 yrs

    Waverley +6.01% · England +5.60%

    −1.32pp

    BP control, under 80

    ≤140/90 · +1.39pp aged 80+

    +1,501

    More patients by 2030

    Forecast 9,398 (18.67%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 16.4% (7,897 patients), above Waverley (15.4%), England (15.2%) and NHS Surrey Heartlands ICB (14.3%). Under-80 blood pressure control fell 1.9% over three years to 67.2% (England +3.2%, ICB +3.8%). Similarly, annual reviews for 671 heart failure patients (1.4% prevalence) fell 6.7% over three years to 65.7% (England +8.7% to 78.5%). Slower progress despite high prevalence may reflect review capacity constraints, unverified locally. Control and review rates lag national trends despite high recorded prevalence, indicating an operational need to prioritise structured clinical recalls.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reached 58.8%, below England (63.6%) and the ICB (59.4%). Statin coverage for diabetes patients without cardiovascular disease was 68.3%, trailing England (73.2%). Fewer at-risk patients receive lipid-lowering therapy than national benchmarks imply, indicating an opportunity to prioritise systematic primary-prevention statin recalls.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202698,811£1.70£2.24£1.86£167,979
    Cardiovascular (all), 2025124,455£4.09£4.74£3.33£509,021

    In 2026, the PCN prescribed 98,811 lipid-regulating items at £1.70 per item, below England (£1.86) and NHS Surrey Heartlands ICB (£2.24). The PCN spent £15,810 less than at England's unit cost and £53,358 less than the ICB's. With unit costs below national and ICB levels, clinical priorities should focus on treatment reach rather than prescribing expenditure.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +10.47%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.53%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.0% (3,204 patients; England 6.6%). Annual reviews rose +10.5% over three years (England +4.4%) to 65.7% (matching England 65.7%), leaving about 1,100 patients unreviewed. For asthma patients aged 6-19, second-hand smoke recording reached 75.5% (252 patients; England 78.8%). Meanwhile, COPD prevalence is 1.3% (641 patients; England 1.9%), and annual reviews trail at 74.1% (England 76.4%). Prioritising unreviewed asthma cases and COPD reviews could support timely care.

    Cancer register and children's immunisation

    Cancer prevalence is 5.5% (2,632 patients; England 3.8%). Childhood immunisation remains strong, with MMR dose 2 at age 5 reaching 95.4% (England 82.8%). However, the 4-in-1 pre-school booster is 94.4% (below the 95.0% target by 0.6 pp), and Grayshott Surgery records a 9.1 pp difference between first (95.5%) and second (86.4%) doses at age five. Timely follow-up may help reduce pre-school coverage gaps.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months97.7%

    England 91.0%

    6-in-1 complete primary course at 24 months97.8%

    England 92.2%

    MMR dose 1 at 24 months98.9%

    England 88.3%

    MMR dose 2 at age 595.4%

    England 82.8%

    4-in-1 pre-school booster at age 594.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    In 2022, 61.4% of cancers with a known stage across NHS Surrey Heartlands ICB were diagnosed at stage 1 or 2 (2,955 of 4,810 staged cancers; 67.7% known-stage coverage across 7,106 registered cancers), 13.6 pp below the 75.0% ambition by 2028 (England 55.3%). Closing this ICB gap requires about 650 additional early-stage diagnoses annually. Stage data reflects the wider ICB system, not PCN performance. Locally, PCN cervical screening uptake is 72.1% (England 66.8%, Waverley 73.8%), falling 0.4% from 2023 to 2025 (England -1.0%, Waverley +1.5%), ranging from 69.0% at Witley Surgery and 69.3% at Grayshott Surgery to 78.8% at Chiddingfold Surgery.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional July 2026 data, Royal Surrey NHS Foundation Trust achieved 82.6% on the 28-day faster diagnosis standard (7.6 pp above the 75.0% standard; England 79.3%, NHS Surrey and Sussex ICB 79.3%). On 62-day referral to treatment, Royal Surrey reached 84.5% (0.5 pp below the 85.0% standard; England 71.2%, ICB 71.5%). In July 2026 diagnostics, Royal Surrey recorded 0.0% waiting 6+ weeks for Colonoscopy and Magnetic Resonance Imaging, but 49.7% for Audiology - Audiology Assessments. Provider waits describe the wider system, not PCN performance.

    Pathways within standard (%)Royal SurreyFrimley HealthSussexSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)82.6287.9574.0179.2979.32
    31-day treatment (96%)96.4392.8976.7990.4592.50
    62-day referral to treatment (85%)84.4881.8465.2071.5171.16
    Diagnostic waits over 6 weeks (%)Royal SurreyFrimley HealthSussexEngland
    MRI0.0012.855.6221.40
    CT0.150.638.579.92
    Echocardiography1.553.350.3928.48
    Colonoscopy0.0022.8439.3530.83
    Gastroscopy0.007.4320.0229.02
    All 15 DM01 tests8.827.4912.9523.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In provisional June 2026 community services data, adults aged 65 and over accounted for 69.6% of community contacts among Waverley borough residents (76,215 of 109,530 contacts). These borough-level figures describe the wider system and are not captured at PCN level.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Chiddingfold870.097.7%75.7%96.6%
    Witley Surgery1100.079.7%62.5%93.4%
    Haslemere940.063.6%75.7%92.8%
    Grayshott Surgery1060.074.6%70.9%89.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWaverleyAssetPCNWaverley
    Care homes (catchment)40 (1,536 beds)n/aSchools (catchment)59n/a
    Children's centres17Places of worship6095
    Librariesn/a4Homelessness support (VCS)0no data
    Day centres (VCS)n/a2Children and young people (VCS)n/a1
    Carers support groups (VCS)n/a1Primary schools (LA maintained)1218
    Primary academies617Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Cardiovascular recall and therapy escalation

    QRISK ≥ 20% lipid therapy is 58.8% (England 63.6%), under-80 BP control fell 1.9% to 67.2% (England +3.2% to 67.8%), and heart failure reviews fell 6.7% to 65.7% (England 78.5%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Combined SMI physical health check recall

    Across 405 SMI patients (0.8% prevalence; 30.8% of Waverley's register), BMI recording is 80.3% (England 82.1%) and BP checks are 83.2% (England 83.4%), with Witley Surgery at 72.7% BP and 71.2% BMI. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Structured asthma and COPD review recall

    Asthma reviews cover 65.7% of 3,204 patients (England 65.7%), leaving 1,099 (about 1,100) unreviewed; COPD reviews reach 74.1% of 641 patients (England 76.4%), with an unadjusted register gap up to 261. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult care coordination (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    SMI physical health check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Under-eighty blood pressure control audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall audit (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Cardiovascular recall and therapy escalation (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Combined SMI physical health check recall (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Option 3 · Structured asthma and COPD review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15